Pharmagen Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2012
2013
Sales/Revenue
4,260.60
4,813.00
Cost of Goods Sold (COGS) incl. D&A
2,996.10
1,767.80
Gross Income
1,264.50
3,045.20
SG&A Expense
3,360.80
5,204.20
Unusual Expense
90.00
833.90
Interest Expense
765.00
3,007.70
Pretax Income
2,771.30
6,000.60
Consolidated Net Income
2,771.30
6,000.60
Net Income
2,771.30
6,000.60
Net Income After Extraordinaries
2,771.30
6,000.60
Net Income Available to Common
2,771.30
6,457.60
Basic Shares Outstanding
351,071.40
383,501.00
Diluted Shares Outstanding
351,071.40
383,501.00
Preferred Dividends
-
457.00
About Pharmagen
View Profile
